PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CORT vs. ETN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CORTETN
YTD Return22.26%30.68%
1Y Return22.87%44.17%
3Y Return (Ann)24.75%27.94%
5Y Return (Ann)23.73%32.82%
10Y Return (Ann)30.31%20.10%
Sharpe Ratio0.341.60
Daily Std Dev55.31%28.18%
Max Drawdown-94.28%-68.95%
Current Drawdown0.00%-8.25%

Fundamentals


CORTETN
Market Cap$4.15B$124.10B
EPS$1.13$9.10
PE Ratio35.1434.26
PEG Ratio0.612.38
Total Revenue (TTM)$569.61M$24.14B
Gross Profit (TTM)$561.03M$9.17B
EBITDA (TTM)$129.11M$4.90B

Correlation

-0.50.00.51.00.2

The correlation between CORT and ETN is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CORT vs. ETN - Performance Comparison

In the year-to-date period, CORT achieves a 22.26% return, which is significantly lower than ETN's 30.68% return. Over the past 10 years, CORT has outperformed ETN with an annualized return of 30.31%, while ETN has yielded a comparatively lower 20.10% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%AprilMayJuneJulyAugustSeptember
62.68%
1.26%
CORT
ETN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CORT vs. ETN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CORT
Sharpe ratio
The chart of Sharpe ratio for CORT, currently valued at 0.34, compared to the broader market-4.00-2.000.002.000.34
Sortino ratio
The chart of Sortino ratio for CORT, currently valued at 0.79, compared to the broader market-6.00-4.00-2.000.002.004.000.79
Omega ratio
The chart of Omega ratio for CORT, currently valued at 1.13, compared to the broader market0.501.001.501.13
Calmar ratio
The chart of Calmar ratio for CORT, currently valued at 0.50, compared to the broader market0.001.002.003.004.005.000.50
Martin ratio
The chart of Martin ratio for CORT, currently valued at 0.93, compared to the broader market-10.000.0010.0020.000.93
ETN
Sharpe ratio
The chart of Sharpe ratio for ETN, currently valued at 1.60, compared to the broader market-4.00-2.000.002.001.60
Sortino ratio
The chart of Sortino ratio for ETN, currently valued at 2.09, compared to the broader market-6.00-4.00-2.000.002.004.002.09
Omega ratio
The chart of Omega ratio for ETN, currently valued at 1.29, compared to the broader market0.501.001.501.29
Calmar ratio
The chart of Calmar ratio for ETN, currently valued at 2.28, compared to the broader market0.001.002.003.004.005.002.28
Martin ratio
The chart of Martin ratio for ETN, currently valued at 7.03, compared to the broader market-10.000.0010.0020.007.03

CORT vs. ETN - Sharpe Ratio Comparison

The current CORT Sharpe Ratio is 0.34, which is lower than the ETN Sharpe Ratio of 1.60. The chart below compares the 12-month rolling Sharpe Ratio of CORT and ETN.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AprilMayJuneJulyAugustSeptember
0.34
1.60
CORT
ETN

Dividends

CORT vs. ETN - Dividend Comparison

CORT has not paid dividends to shareholders, while ETN's dividend yield for the trailing twelve months is around 1.18%.


TTM20232022202120202019201820172016201520142013
CORT
Corcept Therapeutics Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ETN
Eaton Corporation plc
1.18%1.43%2.06%1.76%2.43%3.00%3.85%3.04%3.40%4.23%2.88%2.21%

Drawdowns

CORT vs. ETN - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than ETN's maximum drawdown of -68.95%. Use the drawdown chart below to compare losses from any high point for CORT and ETN. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AprilMayJuneJulyAugustSeptember0
-8.25%
CORT
ETN

Volatility

CORT vs. ETN - Volatility Comparison

Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN) have volatilities of 8.55% and 8.40%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
8.55%
8.40%
CORT
ETN

Financials

CORT vs. ETN - Financials Comparison

This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Eaton Corporation plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items